{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:59:20Z","timestamp":1793037560798,"version":"4.5.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001056","name":"Gallipoli Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.canlet.2026.218566","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:44:05Z","timestamp":1777995845000},"page":"218566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dynamic responses of cancer-associated fibroblasts to therapy in primary liver cancer"],"prefix":"10.1016","volume":"653","author":[{"given":"Qi","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Rong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Bridle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"O'Rourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7811-5148","authenticated-orcid":false,"given":"Xiaowen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218566_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218566_bib2","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn Richard","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218566_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218566_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.14218\/JCTH.2017.00031","article-title":"Current and future treatment of hepatocellular carcinoma: an updated comprehensive review","volume":"6","author":"Daher","year":"2018","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.canlet.2026.218566_bib5","first-page":"141","article-title":"Update in global trends and aetiology of hepatocellular carcinoma","volume":"22","author":"Rawla","year":"2018","journal-title":"Contemp. Oncol."},{"key":"10.1016\/j.canlet.2026.218566_bib6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/SLA.0000000000000710","article-title":"Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis","volume":"261","author":"Tabrizian","year":"2015","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2026.218566_bib7","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1038\/s41598-021-83149-5","article-title":"Clinicopathological characteristics and prognostic factors for intrahepatic cholangiocarcinoma: a population-based study","volume":"11","author":"Yu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218566_bib8","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1186\/s12885-019-6362-1","article-title":"Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma","volume":"19","author":"Liao","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2026.218566_bib9","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.32899","article-title":"Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma","volume":"147","author":"Ruan","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218566_bib10","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218566_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the Stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218566_bib12","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1038\/s41467-022-32283-3","article-title":"A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma","volume":"13","author":"Lu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218566_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.diii.2013.04.015","article-title":"Hepatocellular carcinoma vascularization: from the most common to the lesser known arteries","volume":"95","author":"Cazejust","year":"2014","journal-title":"Diagn. Interventional Imaging"},{"key":"10.1016\/j.canlet.2026.218566_bib14","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218566_bib15","first-page":"957","article-title":"Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma","volume":"21","author":"Chuaysri","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2026.218566_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112263","article-title":"Hepatic stellate cells shape the ECM-disorganized and immunosuppressive microenvironment via CCL11\/CCR3 axis in lenvatinib-treated hepatocellular carcinoma","volume":"138","author":"Qiang","year":"2026","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2026.218566_bib17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.21037\/atm-20-1038","article-title":"Cancer-associated fibroblasts enhance the chemoresistance of CD73(+) hepatocellular carcinoma cancer cells via HGF-Met-ERK1\/2 pathway","volume":"8","author":"Peng","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218566_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cac2.12414","article-title":"Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib","volume":"43","author":"Eun","year":"2023","journal-title":"Cancer Commun."},{"key":"10.1016\/j.canlet.2026.218566_bib19","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1186\/s12885-023-11613-8","article-title":"Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12\/FOLR1","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2026.218566_bib20","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218566_bib21","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"Affo","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218566_bib22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ccell.2016.09.004","article-title":"p62\/SQSTM1 by binding to vitamin D receptor inhibits hepatic stellate cell activity, fibrosis, and liver cancer","volume":"30","author":"Duran","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218566_bib23","article-title":"Cancer-associated fibroblasts: multidimensional players in liver cancer","volume":"15","author":"Pan","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218566_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-024-00747-z","article-title":"Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma","volume":"11","author":"Cheng","year":"2025","journal-title":"Cell Discov."},{"key":"10.1016\/j.canlet.2026.218566_bib25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","article-title":"Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma","volume":"73","author":"Zhang","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218566_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ccell.2023.12.002","article-title":"EGFR-activated myofibroblasts promote metastasis of pancreatic cancer","volume":"42","author":"Mucciolo","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218566_bib27","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.7150\/ijbs.45446","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition via the transglutaminase 2-dependent IL-6\/IL6R\/STAT3 axis in hepatocellular carcinoma","volume":"16","author":"Jia","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2026.218566_bib28","article-title":"Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression","volume":"9","author":"Liu","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218566_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41419-024-07270-9","article-title":"ERG mediates the differentiation of hepatic progenitor cells towards immunosuppressive PDGFR\u03b1+ cancer-associated fibroblasts during hepatocarcinogenesis","volume":"16","author":"Bai","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218566_bib30","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218566_bib31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2026.218566_bib32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-Induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218566_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13045-019-0782-x","article-title":"Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma","volume":"12","author":"Yin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218566_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40364-022-00406-z","article-title":"Advances of cancer-associated fibroblasts in liver cancer","volume":"10","author":"Peng","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.canlet.2026.218566_bib35","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/cas.14537","article-title":"Heterogeneity of cancer-associated fibroblasts: opportunities for precision medicine","volume":"111","author":"Kanzaki","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2026.218566_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184438","article-title":"Phenotypic plasticity of fibroblasts during mammary carcinoma development","volume":"20","author":"Elwakeel","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218566_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.canlet.2026.218566_bib38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2001-17550","article-title":"History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells","volume":"21","author":"Geerts","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.canlet.2026.218566_bib39","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218566_bib40","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/0008-5472.CAN-19-0454","article-title":"Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis","volume":"79","author":"Mizutani","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218566_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011648","article-title":"FMO2(+) cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma","volume":"13","author":"Xu","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218566_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/cas.15609","article-title":"The heterogeneity of cancer-associated fibroblast subpopulations: their origins, biomarkers, and roles in the tumor microenvironment","volume":"114","author":"Yamamoto","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2026.218566_bib43","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218566_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","article-title":"CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.canlet.2026.218566_bib52","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s12967-025-06325-5","article-title":"CAFs activated by YAP1 upregulate cancer matrix stiffness to mediate hepatocellular carcinoma progression","volume":"23","author":"Yan","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218566_bib57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12967-025-06192-0","article-title":"Integration of single-cell and spatial transcriptomics reveals fibroblast subtypes in hepatocellular carcinoma: spatial distribution, differentiation trajectories, and therapeutic potential","volume":"23","author":"Liu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218566_bib73","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.7150\/thno.99046","article-title":"DAB2 (+) macrophages support FAP (+) fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer","volume":"14","author":"Long","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218566_bib47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12964-025-02162-7","article-title":"LAMA4(+) CD90(+) eCAFs provide immunosuppressive microenvironment for liver cancer through induction of CD8(+) T cell senescence","volume":"23","author":"Zhang","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.canlet.2026.218566_bib130","article-title":"Single-cell and spatial transcriptomics delineate the microstructure and immune landscape of intrahepatic cholangiocarcinoma in the leading-edge area","volume":"12","author":"Zuyin","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218566_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008721","article-title":"POSTN(+) cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218566_bib131","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ags3.12249","article-title":"Cancer-associated fibroblasts show heterogeneous gene expression and induce vascular endothelial growth factor A (VEGFA) in response to environmental stimuli","volume":"3","author":"Inoue","year":"2019","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.canlet.2026.218566_bib45","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/jgh.16915","article-title":"Single-cell transcriptomic analysis reveals an aggressive basal-like tumor cell subpopulation associated with poor prognosis in intrahepatic cholangiocarcinoma","volume":"40","author":"Liao","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218566_bib80","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009111","article-title":"Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8(+) T cell infiltration","volume":"12","author":"Gan","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218566_bib74","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218566_bib51","article-title":"Spatial transcriptomics and snRNA-seq expose CAF niches orchestrating dual stromal-immune barriers in hepatocellular carcinoma","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218566_bib61","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","article-title":"Cancer-associated fibroblasts in inflammation and antitumor immunity","volume":"29","author":"Kennel","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218566_bib67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13073-024-01367-8","article-title":"Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma","volume":"16","author":"Jing","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.canlet.2026.218566_bib132","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjae023","article-title":"Single-cell analysis defines LGALS1+ fibroblasts that promote proliferation and migration of intrahepatic cholangiocarcinoma","volume":"16","author":"Cao","year":"2024","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218566_bib46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/gutjnl-2021-326514","article-title":"Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications","volume":"72","author":"Martin-Serrano","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218566_bib48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12885-025-13435-2","article-title":"TGF-\u03b2 signaling orchestrates cancer-associated fibroblasts in the tumor microenvironment of human hepatocellular carcinoma: unveiling insights and clinical significance","volume":"25","author":"Ge","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2026.218566_bib49","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/hep.32483","article-title":"Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression","volume":"76","author":"Wang","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218566_bib50","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1038\/s41467-020-19920-5","article-title":"TGF\u03b2-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts","volume":"11","author":"Grauel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218566_bib54","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","article-title":"Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment","volume":"22","author":"Ma","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218566_bib55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccell.2023.11.010","article-title":"Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma","volume":"42","author":"Sun","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218566_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41698-023-00483-9","article-title":"Single-cell transcriptome sequencing reveals spatial distribution of IL34+ cancer-associated fibroblasts in hepatocellular carcinoma tumor microenvironment","volume":"7","author":"Wang","year":"2023","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218566_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2025.09.001","article-title":"Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218566_bib60","article-title":"Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches","author":"Chen","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.canlet.2026.218566_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1516","article-title":"The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas","volume":"13","author":"Chen","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218566_bib63","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41418-019-0340-7","article-title":"Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment","volume":"27","author":"Liu","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218566_bib64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41419-024-07270-9","article-title":"ERG mediates the differentiation of hepatic progenitor cells towards immunosuppressive PDGFR\u03b1(+) cancer-associated fibroblasts during hepatocarcinogenesis","volume":"16","author":"Bai","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218566_bib65","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12967-025-06192-0","article-title":"Integration of single-cell and spatial transcriptomics reveals fibroblast subtypes in hepatocellular carcinoma: spatial distribution, differentiation trajectories, and therapeutic potential","volume":"23","author":"Liu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218566_bib66","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"Huang","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218566_bib68","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","article-title":"Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics","volume":"43","author":"Liu","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218566_bib69","volume":"122","author":"Chen","year":"2025"},{"key":"10.1016\/j.canlet.2026.218566_bib70","article-title":"Fibroblast atlas: shared and specific cell types across tissues","volume":"11","author":"Liu","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218566_bib71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/HEP.0000000000001283","article-title":"Spatial single-cell proteomics landscape decodes the tumor microenvironmental ecosystem of intrahepatic cholangiocarcinoma","volume":"83","author":"Hong","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218566_bib72","first-page":"950","volume":"vol. 8","author":"Zhu","year":"2025"},{"key":"10.1016\/j.canlet.2026.218566_bib75","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","article-title":"Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"75","author":"Ma","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218566_bib76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41392-024-01887-0","article-title":"Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression","volume":"9","author":"Peng","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218566_bib77","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.celrep.2016.04.019","article-title":"Cancer-associated fibroblasts regulate tumor-initiating cell plasticity in hepatocellular carcinoma through c-Met\/FRA1\/HEY1 signaling","volume":"15","author":"Lau","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218566_bib78","article-title":"Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids","volume":"6","author":"Song","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218566_bib79","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","article-title":"TGF-\u03b2-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218566_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042197","article-title":"Genetic biomarkers of sorafenib response in patients with hepatocellular carcinoma","volume":"25","author":"Giannitrapani","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218566_bib82","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218566_bib83","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41392-023-01317-7","article-title":"Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study","volume":"8","author":"Shi","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218566_bib84","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S2468-1253(24)00247-4","article-title":"Combination locoregional and systemic therapies in hepatocellular carcinoma","volume":"10","author":"Zhong","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218566_bib85","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jgh.12873","article-title":"Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1\u03b1 dependent pathway in hepatocellular carcinoma","volume":"30","author":"Qu","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218566_bib86","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/his.12623","article-title":"Hypoxia after transarterial chemoembolization May trigger a progenitor cell phenotype in hepatocellular carcinoma","volume":"67","author":"Lai","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2026.218566_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114236","article-title":"Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response","volume":"43","author":"Lior","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218566_bib88","doi-asserted-by":"crossref","first-page":"99359","DOI":"10.18632\/oncotarget.22078","article-title":"Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: a biopsy and resection matched study","volume":"8","author":"Nahm","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218566_bib89","article-title":"An \u03b1-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer","author":"Q Ruan","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218566_bib90","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3892\/mmr.2014.2689","article-title":"Hypoxia-induced secretion of platelet-derived growth factor-BB by hepatocellular carcinoma cells increases activated hepatic stellate cell proliferation, migration and expression of vascular endothelial growth factor-A","volume":"11","author":"Lu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2026.218566_bib91","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/gutjnl-2020-322493","article-title":"Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma","volume":"71","author":"Aoki","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218566_bib92","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yexcr.2015.03.023","article-title":"Receptor channel TRPC6 orchestrate the activation of human hepatic stellate cell under hypoxia condition","volume":"336","author":"Iyer","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2026.218566_bib93","article-title":"Cancer-associated fibroblasts enact field cancerization by promoting extratumoral oxidative stress","volume":"8","author":"Chan","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218566_bib94","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1002\/ctm2.41","article-title":"Oxidative stress induces monocyte-to-myofibroblast transdifferentiation through p38 in pancreatic ductal adenocarcinoma","volume":"10","author":"Huang","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218566_bib95","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40364-024-00656-z","article-title":"Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma","volume":"12","author":"Jiang","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.canlet.2026.218566_bib96","doi-asserted-by":"crossref","first-page":"eabm1831","DOI":"10.1126\/sciadv.abm1831","article-title":"Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218566_bib97","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1038\/s41467-023-43670-9","article-title":"SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma","volume":"14","author":"Man","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218566_bib98","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41467-024-44795-1","article-title":"Macro CD5L(+) deteriorates CD8(+)T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma","volume":"15","author":"Lu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218566_bib99","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1084\/jem.20131195","article-title":"Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A","volume":"210","author":"Lotti","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2026.218566_bib100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.radonc.2015.05.007","article-title":"Impact of neoadjuvant therapy on cancer-associated fibroblasts in rectal cancer","volume":"116","author":"Verset","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218566_bib101","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.matbio.2022.08.002","article-title":"Chemotherapy treatment induces pro-invasive changes in liver ECM composition","volume":"112","author":"Guarin","year":"2022","journal-title":"Matrix Biol."},{"key":"10.1016\/j.canlet.2026.218566_bib102","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1038\/s41467-021-24009-8","article-title":"Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance","volume":"12","author":"Pietil\u00e4","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218566_bib103","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1158\/0008-5472.CAN-24-4165","article-title":"Chemotherapy-treated breast cancer cells activate the WNT signaling pathway to enter a diapause-like early persister state","volume":"86","author":"El Laithy","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218566_bib104","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1038\/onc.2015.7","article-title":"PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing \u03b2-catenin expression and nuclear translocation","volume":"34","author":"Liu","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218566_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/cells12081141","article-title":"Impact of aberrant \u03b2-Catenin pathway on cholangiocarcinoma heterogeneity","volume":"12","author":"Lozano","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218566_bib106","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1158\/0008-5472.CAN-20-0263","article-title":"A wnt-induced phenotypic switch in cancer-associated fibroblasts inhibits EMT in colorectal cancer","volume":"80","author":"Mosa","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218566_bib107","article-title":"Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics","volume":"4","author":"Qin","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.canlet.2026.218566_bib53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41588-024-01998-y","article-title":"Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer","volume":"57","author":"Yan","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218566_bib108","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41467-024-45595-3","article-title":"Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway","volume":"15","author":"Licaj","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218566_bib109","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13073-023-01218-y","article-title":"Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence","volume":"15","author":"Zhang","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.canlet.2026.218566_bib110","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1158\/1078-0432.CCR-21-3570","article-title":"Immunostimulatory cancer-associated fibroblast subpopulations can predict immunotherapy response in head and neck cancer","volume":"28","author":"Obradovic","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218566_bib111","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218566_bib112","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1158\/0008-5472.CAN-17-0524","article-title":"Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation","volume":"78","author":"Tommelein","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218566_bib113","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12964-023-01093-5","article-title":"Cancer-associated fibroblasts in radiotherapy: bystanders or protagonists?","volume":"21","author":"Martinez-Zubiaurre","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.canlet.2026.218566_bib114","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009852","article-title":"4-1BB agonist targeted to fibroblast activation protein \u03b1 synergizes with radiotherapy to treat murine breast tumor models","volume":"13","author":"Garate-Soraluze","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218566_bib115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ccell.2022.01.004","article-title":"Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer","volume":"40","author":"Nicolas","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218566_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2025.102251","article-title":"Interferon-driven CAF reprogramming augments immunogenic response to neoadjuvant radiotherapy in colorectal cancer","author":"Huang","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.canlet.2026.218566_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216799","article-title":"Characterization of the distinct immune microenvironments between hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"588","author":"Jiang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218566_bib118","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2468-1253(23)00111-5","article-title":"Fibroblasts in liver cancer: functions and therapeutic translation","volume":"8","author":"Affo","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218566_bib119","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.7150\/ijms.6868","article-title":"FGFR4 and TGF-\u03b21 expression in hepatocellular carcinoma: correlation with clinicopathological features and prognosis","volume":"10","author":"Chen","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.canlet.2026.218566_bib120","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1002\/cam4.3880","article-title":"Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma","volume":"10","author":"Harding","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2026.218566_bib121","first-page":"44","article-title":"Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer","volume":"26","author":"Hofheinz","year":"2003","journal-title":"Onkologie"},{"key":"10.1016\/j.canlet.2026.218566_bib122","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4161\/cbt.6.11.4874","article-title":"Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast Activation protein in patients with metastatic colorectal cancer","volume":"6","author":"Narra","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2026.218566_bib123","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157399","article-title":"Targeting FAP\u03b1-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models","volume":"132","author":"Qi","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218566_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137197","article-title":"Diagnostic performances of PET\/CT using fibroblast activation protein inhibitors in patients with primary and metastatic liver tumors: a comprehensive literature review","volume":"25","author":"Manuppella","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218566_bib125","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s00259-023-06211-6","article-title":"Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition","volume":"50","author":"Zboralski","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.canlet.2026.218566_bib126","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41392-024-01853-w","article-title":"Antitumor efficacy and potential mechanism of FAP-Targeted radioligand therapy combined with immune checkpoint blockade","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218566_bib127","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218566_bib128","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/cam4.1998","article-title":"Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment","volume":"8","author":"Tarao","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2026.218566_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.104110","article-title":"Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial","volume":"10","author":"Piscaglia","year":"2025","journal-title":"ESMO Open"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T20:42:19Z","timestamp":1780951339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526003290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":132,"alternative-id":["S0304383526003290"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218566","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic responses of cancer-associated fibroblasts to therapy in primary liver cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218566"}}